INS and obesity due to melanocortin 4 receptor deficiency: Studies have documented links between obesity and elevated levels of free circulating hormones (e.g., insulin and estradiol) and their impact on hormone-dependent cancers [15, 40–42] such as breast and prostate cancer. These differences likely underlie the reported differential effects of obesity on cancer subtypes.